Oxford University Press, The Journal of Infectious Diseases, 9(209), p. 1343-1353, 2013
Full text: Download
Background. High mortality and uncertainty about the effectiveness of neuraminidase inhibitors (NAIs) in humans infected with influenza A(H7N9) viruses are public health concerns.